Inogen | INGN - Przychody Ze Sprzedaży





Obroty Zmiana Data
Abbott USD 11.46B 90M 2025-12
Accuray USD 116.17M 14.63M 2024-12
AngioDynamics USD 79.43M 3.72M 2025-09
Artivion USD 115.99M 2.6M 2025-12
AtriCure USD 140.5M 6.2M 2025-12
Baxter International USD 2.97B 130M 2025-12
Becton, Dickinson and Co. USD 5.3B 600M 2025-12
Boston Scientific USD 5.29B 220M 2025-12
Chart Industries USD 1.08B 20M 2025-12
Cooper Companies USD 1.02B 41.1M 2025-12
Dexcom USD 1.26B 50M 2025-12
Edwards Lifesciences USD 1.57B 20M 2025-12
Globus Medical USD 826.4M 57.4M 2025-12
Inogen USD 74.93M 504K 2024-09
Insulet USD 783.8M 77.5M 2025-12
Masimo USD 412.5M 41M 2025-12
Medtronic USD 9B 39M 2026-01
Orthofix International USD 219.91M 14.28M 2025-12
Philips EUR 5.1B 797M 2025-12
ResMed USD 1.4B 100M 2025-12
Steris USD 1.5B 470M 2025-12
Stryker USD 7.2B 1.14B 2025-12
Tandem Diabetes Care USD 290.4M 41.15M 2025-12
Teleflex USD 568.98M 344.02M 2025-12
X T L Biopharmaceuticals USD 289K 127K 2024-12
Zimmer Biomet Holdings USD 2.24B 240M 2025-12